Tyson, Pilgrim’s Pride, and Sanderson Farms all took a dive on Friday, driven solely by a report by the small Wall Street equity research shop Pivotal Research. Hundreds of millions in market value has been wiped out for these companies, all based on one analyst’s conclusion that a lawsuit regarding industry collusion on chicken prices; a lawsuit most investors have known about for more than a month now.
Tyson is obviously remaining tight-lipped regarding pending litigation, but it still took the time to issue a press release calling the report “speculative” and that the company had not changed business practices based on the litigation, a claim that was made in the report.
The lawsuit is simple in its claim. Brought forth by Maplevale Farms, a large food service provider. It alleges that major players in the poultry industry worked in concert to cut production, colluding to manage broiler supply and keep prices inflated by exchanging proprietary data through a service called Agri Stats. Basically, a chicken cartel. By sharing proprietary information (via Agri Stats) and discussion between senior management, the industry kept chicken prices high.
Full Content: Seeking Alpha
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas